The psychological effects of recreational PDE5 inhibitor use

Nature Reviews Urology

Volumn 9, Issue 9, 2012, Pages 479-480

  Melnik, Tamara ^a  

^a R Martiniano de Carvalho   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; ILLICIT DRUG; KETAMINE; METHAMPHETAMINE; NITRITE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

BISEXUALITY; ERECTILE DYSFUNCTION; HOMOSEXUALITY; HUMAN; MALE; PENIS ERECTION; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOGENIC IMPOTENCE; PSYCHOTHERAPY; RECREATION; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; SUBSTANCE ABUSE; ADOLESCENT; ADULT; DRUG UTILIZATION; NOTE;

ADOLESCENT; DRUG UTILIZATION; ERECTILE DYSFUNCTION; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; RECREATION; YOUNG ADULT;

EID: 84865956309     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.149     Document Type: Short Survey

References (9)

1. Althof, S.E. When an erection alone is not enough: biopsychosocial obstacles to lovemaking. Int. J. Impot. Res. 14, S99-104 (2002).
2. Harte, C.B. & Meston, C.M. Recreational use of erectile dysfunction medications and its adverse effects on erectile function in young healthy men: the mediating role of confidence in erectile ability. J. Sex. Med. 9, 1852-1859 (2012).
3. Melnik, T., Abdo, C.H., de Moraes, J.F. & Riera, R. Satisfaction with the treatment, confidence and 'naturalness' in engaging in sexual activity in men with psychogenic erectile dysfunction: preliminary results of a randomized controlled trial of three therapeutic approaches. BJU Int. 109, 1213-1219 (2012).
4. Harte, C.B. & Meston, C.M. Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors. Arch. Sex. Behav. 40, 597-606 (2011).
5. Korkes, F., Costa-Matos, A., Gasperini, R., Reginato, P.V. & Perez, M.D.C. Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students. J. Sex. Med. 5, 2414-2418 (2008).
6. Bechara, A., Casabé, A., De Bonis, W., Helien, A. & Bertolino, M.V. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J. Sex. Med. 7, 3736-3742 (2010).
7. Cachay, E., Mar-Tang, M. & Mathews, W.C. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDS 18, 349-354 (2004). (Pubitemid 38821791)
8. Swearingen, S.G. & Klausner, J.D. Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am. J. Med. 118, 571-577 (2005). (Pubitemid 40732693)
9. Melnik, T., Soares, B.G. & Nasello, A.G. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J. Sex. Med. 5, 2562-2574 (2008).